Abstract
Purpose
This study aimed to assess subclinical peripheral diabetic neuropathy (PDN) in adolescents with type 1 diabetes mellitus (T1DM).
Methods
Subjects included 53 T1DM patients (age (mean ± SE): 15.8 ± 0.54 years, disease duration: 6.0 ± 0.51 years and HbA1c: 7.9 ± 0.19%), and 37 healthy gender matched controls (age: 15.6 ± 0.52 years). PDN was assessed by vibration perception threshold (VPT) and by quantitative sensory testing (QST). In controls, 95% confidence intervals were calculated.
Results
Among patients, VPT prevalence of abnormality ranged from 60–73.4% on different sites. Higher VPT was found in patients on all examined sites (p < 0.01). In controls, VPT correlated with height (r = 0.48, p = 0.05). Regarding QST prevalence of abnormality, cold detection threshold (CDT) ranged 7.3–39.0%, cold pain threshold (CPT) ranged 22.22–29.63%, hot detection threshold (HDT) ranged 34.14–63.41%, and hot pain threshold (HPT) ranged 15.79–36.84%. In patients, CPT correlated with BMI (r = 0.42, p = 0.05) and diabetes duration, (r = 0.40, p = 0.05), HPT correlated with age (r = 0.36, p = 0.05) and height (r = 0.35, p = 0.05), while in controls with BMI (r = 0.51, p = 0.05). No correlation of VPT or QST with HbA1c was observed.
Conclusion
Adolescents with T1DM in this study, although asymptomatic, showed a high prevalence of impaired indices of PDN, highlighting potential clinical implications of early identification of PDN.
Similar content being viewed by others
References
R. Pop-Busui, A.J.M. Boulton, E.L. Feldman et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diab. Care 40(1), 136–154 (2017)
M. Louraki, C. Tsentidis, D. Kallinikou, M. Katsalouli, C. Kanaka-Gantenbein, N. Kafassi, A. Papathanasiou, K. Karavanaki, Reproducibility of vibration perception threshold values in children and adolescents with type 1 diabetes mellitus and associated factors. Prim. Care Diab 8(2), 147–157 (2014)
D. Lacomis, Small fiber neuropathy. Muscle Nerve 26, 173–188 (2002)
F.W. Bertelsmann, J.J. Heimans, J.C. van Rooy et al. Reproducibility of vibratory perception thresholds in patients with diabetic neuropathy. Diab. Res 3, 463–466 (1986)
F. Abad, N.M. Diaz-Gomez, I. Rodriguez, R. Perez, J.A. Delgado, Subclinical pain and thermal sensory dysfunction in children and adolescents with type 1 diabetes mellitus. Diabet. Med. 19, 827–831 (2002)
S.J. Bird, M.J. Brown, C. Spino, S. Watling, H.L. Foyt, Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve 34(2), 214–224 (2006)
J. Fagius, L.K. Wahren, Variability of sensory thresholddetermination in clinical use. J. Neurol. Sci. 51, 11–27 (1981)
G. Gruener, P.J. Dyck, Quantitative sensory testing: methodology, applications, and future directions. J. Clin. Neurophysiol. 11, 568–583 (1994)
H. Nodera et al. Epidermal reinnervation concomitant with symptomatic improvement in a sensory neuropathy. Muscle Nerve 27, 507–509 (2003)
K.A. Sveen, B. Karime, E. Jorum, S.I. Mellgren, M.W. Fagerland, V.M. Monnier, K. Dahl-Jorgensen, K.F. Hanssen, Small and large fiber neuropathy after 40 years of T1DM. Diabet. Care 36, 3712–3717 (2013)
N. Weintrob, I. Amitay, P. Lilos, S. Shalitin, L. Lazar, Z. Josefsberg, Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents and young adults with type 1 diabetes. J. Diab. Complic. 21, 13–17 (2007)
M. Louraki, M. Katsalouli, C. Kanaka-Gantenbein, N. Kafasi, E. Critselis, D. Kallinikou, C. Tsentidis, K. Karavanaki, The prevalence of early subclinical somatic neuropathy in children and adolescents with type 1 dibetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). Diab Res Clin. Pr. 117, 82–90 (2016)
K.E. Galluzzi, Managing neuropathic pain. J. Am. Osteopath Assoc. 107(suppl 6), ES39–ES48 (2007)
B.S. Olsen, A. Sjolie, P. Hougaard, J. Johannesen, K. Borch-Johnsen, K. Marinelli et al. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J. Diab. Compl 14, 295–300 (2000)
D. Lacomis, Small-fiber neuropathy. Muscle Nerve 26, 173–188 (2002)
G.L. Pittenger et al. Intraepidermal nerve fibers are indicators of small – fiber neuropathy in both diabetic and nondiabetic patients. Diab. Care 27, 1974–1979 (2004)
C.T. Shun et al. Skin denervation in type 2 diabetes : correlation with diabetic duration and functional impairments. Brain 127, 1593–1605 (2004)
K.A. Sveen et al. Small- and large- fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study. Diab. Care 36(11), 3712d pro (2013)
S.-L. Lv, C. Fang, J. Hu, Y. Huang, B. Yang, R. Zou et al. https://doi.org/10.1016/j.diabres.2015.04.018
The DCCT Research Group. Factors in development of diabetic neuropathy, Baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT). Diabetes 37, 476–481 (1988)
H.H. Kramer, R. Rolke, A. Bickel, F. Birklein, Thermal thresholdw predict painfulness of diabetic neuropathies 2386–2391 (2004).
D.S. Kim, C.H. Yoon, S.J. Lee, S.Y. Park, H.J. Yoo, H.J. Cho, Changes in voltage-gated calcium channel alpha (1) gene expression in rat dorsal root ganglia following peripheral nerve injury. Brain Res. Mol. Brain Res 96, 151–156 (2001)
G.M. Pitcher, J.L. Henry, Cellular mechanisms of hyperalgesia and spontaneous pain in spinalized rat model of peripheral neuropathy : changes in myelinated afferent inputs implicated. Eur. J. Neurosci. 12, 2006–2020 (2000)
S. Fitzek, U. Baumgartner, C. Fitzek, W. Margerl, P. Urban, F. Thomke, J. Marx, R.D. Treede, P. Stoeter, H.C. Hopf, Mechanisms and predictors of chronic facial pain in lateral medullary infarction. Ann. Neurol. 49, 493–500 (2001)
A.E. Panerai, P. Sacerdote, A. Brini, M. Bianchi, P. Mantegazza, Autonomy and central nervous system neuropeptides aftersection of the sciatic nerve in rats of different strains. Pharm. Biochem Behav. 28, 385–388 (1987)
U. Breitinger, H.G. Breitinger, Excitatory and inhibitory neuronal signaling in inflammatory and diabetic neuropathic pain. Mol. Med. 29(1), 53 (2023).
H. Chen, T.J. Lamer, R.H. Rho et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin. Proc. 79, 1533–1545 (2004)
W.C. Kwowler, E. Barrett – Connor, S.E. Fowler et al. Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002)
S.T. Britland, R.J. Young, A.K. Sharma, B.F. Clarke, Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain 48, 361–370 (1992)
X. Zhang et al. Clinical characteristics and risk factors of diabetic peripheral neuropathy of type 1 diabetes mellitus patients. Diab. Res. Clin. Pract. 129, 97ts (2017)
Author information
Authors and Affiliations
Contributions
Conceptualization/visualization, A.S., P.K. and K.K.; methodology, P.K., G.P., K.K. ; validation, X.X., Y.Y. and Z.Z.; formal analysis, K.P., P.G., K.K.; data acquisition, A.S., K.P., B.C., K.G., S.I-I., K.K.; writing—original draft preparation, A.S., B.C., K.G., K.S., S.I-I.; writing—review and editing, K.P., P.G., K.K.; supervision, P.K., K.K. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Stavroula, A., Panagiotis, K., George, P. et al. Assessment of small nerve fiber function as an early marker of peripheral neuropathy in children and adolescents with type 1 diabetes mellitus (T1DM). Endocrine (2024). https://doi.org/10.1007/s12020-024-03991-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03991-1